Susquehanna International Group
AMED

Susquehanna International Group’s Amedisys AMED Stock Holding History

Susquehanna International Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-23,400
Closed -$2.3M – 12283
2025
Q2 		$2.3M Buy
23,400
+12,600
+117% +$1.19M ﹤0.01% 5501
2025
Q1 		$1M Sell
10,800
-7,600
-41% -$701K ﹤0.01% 7261
2024
Q4 		$1.67M Sell
18,400
-100
-0.5% -$9.18K ﹤0.01% 5707
2024
Q3 		$1.79M Sell
18,500
-1,600
-8% -$156K ﹤0.01% 5507
2024
Q2 		$1.85M Sell
20,100
-1,300
-6% -$121K ﹤0.01% 5246
2024
Q1 		$1.97M Sell
21,400
-12,400
-37% -$1.16M ﹤0.01% 5379
2023
Q4 		$3.21M Buy
33,800
+21,100
+166% +$1.97M ﹤0.01% 4452
2023
Q3 		$1.19M Sell
12,700
-11,800
-48% -$1.09M ﹤0.01% 6253
2023
Q2 		$2.24M Buy
+24,500
New +$2.01M ﹤0.01% 4923
2023
Q1 		– Sell
-2,500
Closed -$209K – 12490
2022
Q4 		$209K Sell
2,500
-37,400
-94% -$3.37M ﹤0.01% 10025
2022
Q3 		$3.86M Buy
39,900
+6,800
+21% +$811K ﹤0.01% 3583
2022
Q2 		$3.48M Sell
33,100
-700
-2% -$89.4K ﹤0.01% 3814
2022
Q1 		$5.82M Buy
33,800
+12,700
+60% +$1.9M ﹤0.01% 3380
2021
Q4 		$3.42M Sell
21,100
-35,500
-63% -$5.71M ﹤0.01% 4424
2021
Q3 		$8.44M Buy
56,600
+51,200
+948% +$10.6M ﹤0.01% 3119
2021
Q2 		$1.32M Sell
5,400
-9,400
-64% -$2.47M ﹤0.01% 6981
2021
Q1 		$3.92M Buy
14,800
+1,400
+10% +$395K ﹤0.01% 4396
2020
Q4 		$3.93M Sell
13,400
-10,200
-43% -$2.62M ﹤0.01% 3844
2020
Q3 		$5.58M Sell
23,600
-25,900
-52% -$5.89M ﹤0.01% 2914
2020
Q2 		$9.83M Sell
49,500
-9,300
-16% -$1.73M ﹤0.01% 2153
2020
Q1 		$10.8M Buy
58,800
+23,200
+65% +$4.13M ﹤0.01% 1657
2019
Q4 		$5.94M Sell
35,600
-7,200
-17% -$1.07M ﹤0.01% 2739
2019
Q3 		$5.61M Buy
42,800
+8,600
+25% +$1.12M ﹤0.01% 2571
2019
Q2 		$4.15M Sell
34,200
-15,200
-31% -$1.8M ﹤0.01% 2972
2019
Q1 		$6.09M Buy
49,400
+25,400
+106% +$3.19M ﹤0.01% 2237
2018
Q4 		$2.81M Buy
24,000
+4,800
+25% +$566K ﹤0.01% 3036
2018
Q3 		$2.4M Sell
19,200
-68,700
-78% -$7.59M ﹤0.01% 3710
2018
Q2 		$7.51M Buy
87,900
+77,400
+737% +$5.68M ﹤0.01% 2246
2018
Q1 		$634K Sell
10,500
-6,600
-39% -$376K ﹤0.01% 6164
2017
Q4 		$901K Sell
17,100
-35,900
-68% -$1.89M ﹤0.01% 5445
2017
Q3 		$2.97M Buy
53,000
+39,900
+305% +$2.11M ﹤0.01% 3248
2017
Q2 		$823K Sell
13,100
-12,600
-49% -$734K ﹤0.01% 5675
2017
Q1 		$1.31M Buy
25,700
+16,500
+179% +$787K ﹤0.01% 4559
2016
Q4 		$392K Buy
9,200
+1,000
+12% +$42.5K ﹤0.01% 7454
2016
Q3 		$389K Buy
8,200
+4,100
+100% +$205K ﹤0.01% 6511
2016
Q2 		$207K Sell
4,100
-10,200
-71% -$515K ﹤0.01% 7554
2016
Q1 		$691K Sell
14,300
-86,900
-86% -$3.35M ﹤0.01% 5821
2015
Q4 		$3.98M Sell
101,200
-14,700
-13% -$588K ﹤0.01% 2843
2015
Q3 		$4.4M Buy
115,900
+4,500
+4% +$190K ﹤0.01% 2865
2015
Q2 		$4.43M Sell
111,400
-18,000
-14% -$561K ﹤0.01% 3114
2015
Q1 		$3.46M Buy
129,400
+12,500
+11% +$353K ﹤0.01% 3296
2014
Q4 		$3.43M Sell
116,900
-9,700
-8% -$240K ﹤0.01% 3504
2014
Q3 		$2.55M Sell
126,600
-93,900
-43% -$1.81M ﹤0.01% 4181
2014
Q2 		$3.69M Buy
220,500
+140,000
+174% +$1.98M ﹤0.01% 3563
2014
Q1 		$1.2M Buy
80,500
+900
+1% +$13.9K ﹤0.01% 5191
2013
Q4 		$1.17M Sell
79,600
-196,000
-71% -$3.16M ﹤0.01% 5233
2013
Q3 		$4.75M Buy
275,600
+13,200
+5% +$196K ﹤0.01% 2816
2013
Q2 		$3.05M Buy
+262,400
New +$3.01M ﹤0.01% 3253

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna International Group's AMED Position: Q2 2025 in Review

Susquehanna International Group sold out of Amedisys (AMED) in Q2 2025, closing a stake of 6,440 shares — an estimated $609K sold.

Susquehanna International Group first reported a position in AMED in Q4 2013 and held it in 33 quarters. The position peaked at $13.6M in Q2 2023. 320 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • Susquehanna International Group reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 6,440 Amedisys shares in Q2 2025, an estimated $609K.
  • Susquehanna International Group first reported a position in Amedisys in Q4 2013 and held it in 33 quarters.
  • Susquehanna International Group's Amedisys position peaked at $13.6M in Q2 2023.
  • 320 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.